Active Motif is a provider of epigenetic research assays, reagents, and services. The company is building a platform based on its patented transposase-based technologies to simplify the interrogation of chromatin, the dynamics of histone modifications, chromatin remodeling, DNA methylation, transcription factor binding, as well as short and long range gene regulation by non-coding regulatory regions. Active Motif’s bioinformatics platform can take the data generated by these techniques and provide powerful insights into the epigenetic changes occurring in disease or in response to drugs.
This data can be integrated with other OMICs data to develop a comprehensive understanding of the disease landscape and ultimately result in actionable and tailored treatments based on patient stratification.
